Enovis Corporation (ENOV)

51,05 +0,38 (+0,75%) Börsenschluss: 04:00PM EDT

Enovis Corporation

2711 Centerville Road
Suite 400
Wilmington, DE 19808
United States
302 252 9160
https://www.enovis.com

Sektor(en): Industrials
Branche: Specialty Industrial Machinery
Vollzeitmitarbeiter: 6.550

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Matthew L. Trerotola	CEO & Chairman	3,35M	N/A	1967
Mr. Phillip Benjamin Berry	Senior VP & CFO	1,08M	N/A	1979
Ms. Patricia A. Lang	Senior VP & Chief Human Resources Officer	1,01M	N/A	1959
Mr. Daniel A. Pryor	Executive Vice President of Strategy & Business Development	1,29M	N/A	1968
Mr. Brady R. Shirley	Executive Advisor & Director	2,02M	N/A	1966
Mr. John Kleckner	VP, Controller & Chief Accounting Officer	N/A	N/A	1977
Derek Leckow	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Bradley J. Tandy	Senior VP & Chief Legal Officer	N/A	N/A	1959
Katie Sweet	Vice President of Corporate Communication	N/A	N/A	N/A
Mr. Terry Ross	Group President Prevention & Recovery	N/A	N/A	1970

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Corporate Governance

Enovis Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 2. Die grundlegenden Scores sind Audit: 5, Vorstand: 3, Shareholderrechte: 2, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.